Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples